Primary Immunodeficiency Type 2 NEW

@article{pmid38535207,

title = {A Novel  Immunodeficiency Identified in a Subset of Cavalier King Charles Spaniels with  and  Pneumonia},

author = {Emily L Coffey and Liang Ma and Ousmane H Cissé and Joseph A Kovacs and Katie M Minor and Antti Sukura and Patrizia Danesi and Steven G Friedenberg and Jonah N Cullen and Christiane Weissenbacher-Lang and Julie C Nadeau and Amber M Graham and Martin N Granick and Natalie K Branson and Kyle C Branson and Barbara Blasi and Casandra M Jacobs and Eva Furrow},

doi = {10.3390/jof10030198},

issn = {2309-608X},

year  = {2024},

date = {2024-03-01},

urldate = {2024-03-01},

journal = {J Fungi (Basel)},

volume = {10},

number = {3},

abstract = {Pet dogs are a valuable natural animal model for studying relationships between primary immunodeficiencies and susceptibility to  and other opportunistic respiratory pathogens. Certain breeds, such as the Cavalier King Charles Spaniel, are over-represented for  pneumonia (PCP), suggesting the presence of a primary immunodeficiency in the breed. Here, we report the discovery of a  nonsense variant in three Cavalier King Charles Spaniel dogs with either PCP (n = 2) or refractory  pneumonia (n = 1).  encodes a protein that plays critical roles in T-cell activation and other aspects of immune function. Deleterious  variants have recently been reported in human patients with PCP and other recurrent pneumonias. In addition to opportunistic respiratory infection, the affected dogs also exhibited other clinical manifestations of CARMIL2 deficiencies that have been reported in humans, including early-onset gastrointestinal disease, allergic skin disease, mucocutaneous lesions, abscesses, autoimmune disorders, and gastrointestinal parasitism. This discovery highlights the potential utility of a natural canine model in identifying and studying primary immunodeficiencies in patients affected by PCP.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}